Answers are grounded in this paper and cite their sources.
This work confirms that the procedures and requirements for the clinical trial application of a paediatric trial are different. In the European Union, the timeframes for submission were generally harmonised but longer. In non-European countries, delays were caused by national dispositions but the entire authorisation process resulted faster with less requests from ECs/CAs. The upcoming application of Regulation (EU) 536/2014 is expected to harmonise practices in Europe and possibly outside. Networks on paediatric research acting at international level will be crucial in this effort.
No takes yet. Share an insight, caveat, or question.
Giannuzzi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: